2 days Ago By Defense World Staff
Commonwealth Equity Services LLC purchased a new stake in shares of Assertio Holdings, Inc. ( NASDAQ:ASRT – Free Report ) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 34,101 shares of the company’s stock, valued at approximately $30,000.
Other hedge funds have also recently made changes to their positions in the company. Thurston Springer Miller Herd & Titak Inc. lifted its position in Assertio by 33.
7% during the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 67,500 shares of the company’s stock valued at $59,000 after buying an additional 17,000 shares during the period.
Palumbo Wealth Management LLC increased its stake in shares of Assertio by 10.6% in the 4th quarter. Palumbo Wealth Management LLC now owns 205,598 shares of the company’s stock worth $179,000 after acquiring an additional 19,637 shares in the last quarter.
Captrust Financial Advisors purchased a new position in Assertio during the 3rd quarter valued at about $26,000. Empowered Funds LLC boosted its stake in Assertio by 5.4% during the fourth quarter.
Empowered Funds LLC now owns 455,282 shares of the company’s stock worth $397,000 after acquiring an additional 23,369 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in Assertio by 4.1% in the third quarter.
Geode Capital Management LLC now owns 1,074,852 shares of the company’s stock worth $1,269,000 after purchasing an additional 42,750 shares during the period. 48.96% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth ASRT has been the subject of a number of analyst reports. HC Wainwright decreased their target price on shares of Assertio from $4.00 to $3.
50 and set a “buy” rating for the company in a research note on Wednesday, March 19th. StockNews.com lowered Assertio from a “buy” rating to a “hold” rating in a research report on Monday, March 17th.
Finally, Industrial Alliance Securities set a $1.75 target price on Assertio in a report on Friday, March 14th. Assertio Stock Up 3.
3 % Shares of Assertio stock opened at $0.62 on Friday. The company has a 50-day simple moving average of $0.
74 and a two-hundred day simple moving average of $0.88. The stock has a market capitalization of $59.
38 million, a PE ratio of -0.85, a price-to-earnings-growth ratio of 3.25 and a beta of 0.
56. Assertio Holdings, Inc. has a 52-week low of $0.
51 and a 52-week high of $1.80. The company has a debt-to-equity ratio of 0.
30, a quick ratio of 1.57 and a current ratio of 2.01.
About Assertio ( Free Report ) Assertio Holdings, Inc, a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. Featured Articles Five stocks we like better than Assertio Options Trading – Understanding Strike Price JPMorgan is a Buy, if You Can Handle The Volatility P/E Ratio Calculation: How to Assess Stocks United States Steel’s Crash: An Unmissable Buying Opportunity What Are Dividend Challengers? Rocket Lab Stock: Weathering the Storm, Time for a Comeback? Want to see what other hedge funds are holding ASRT? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Assertio Holdings, Inc. ( NASDAQ:ASRT – Free Report ). Receive News & Ratings for Assertio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assertio and related companies with MarketBeat.
com's FREE daily email newsletter ..
